Tag: lymphedema

April 16, 2018 Off

Investigational gene therapy product Lymfactin for the treatment of secondary lymphedema tested in phase 1 study

Herantis Pharma has gotten positive results from a safety evaluation in the ongoing Phase 1 clinical study of its investigational…

March 6, 2017 Off

Herantis marks lymphedema awareness day with progres in the disease study

By Dino Mustafić

Herantis Pharma clinical study with the company’s innovative gene therapy investigational product Lymfactin for the treatment of secondary lymphedema has advanced to highest planned dose level owing to good reported safety.